Breast Surgeons Live

 Back to Activities List

Session Title:
Breast Surgery for the General Surgeon (Part 2)
Date & Time:
January 29, 2025, 7:00 PM–9:00 PM ET
Length:
2 Hours
CME Deadline:
January 29, 2026

This activity is open to members and nonmembers:

Log in / Create Account
Target Audience:
Surgeons with a special interest in the treatment of breast disease.
Objectives:
At the end of this activity, participants will be able to:
  • Recognize when to utilize systemic therapy (endocrine, immunotherapy, targeted or chemotherapy) prior to surgery
  • Improve ability to provide flat aesthetic closure following mastectomy or offer oncoplastic breast conservation when appropriate
  • Determine which patients with atypical breast biopsy require a surgical excision
  • Understand the indications for post mastectomy radiation therapy
  • Manage idiopathic granulomatous mastitis and other benign breast processes
Description:
This 2-part course will offer the latest updates in the surgical management of patients with breast cancer and benign breast disease. Topics include management of the axilla (when to dissect, when not, when to perform sentinel lymph node surgery, when not), indications for neoadjuvant chemotherapy or endocrine therapy, indications for post mastectomy radiation, tips to optimize cosmetic outcome in breast surgery, as well as management of breast abscesses, granulomatous mastitis, and atypical biopsies. Our speakers will offer technical tips, most up to date clinical algorithms and case studies that general surgeons can incorporate immediately into their practice.
Agenda:
7:00–7:03 pm — Welcome and Introduction
Kari Rosenkranz, MD
7:03–7:15 pm — Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
Chandler Cortina MD, MS
7:15–7:18 pm — Case Presentation
7:18–7:30 pm — Neoadjuvant Chemotherapy for HER2+ disease
Zahraa Al-Hilli, MD, MBA
7:30–7:33 pm — Case Presentation
7:33–7:45 pm — Neoadjuvant Chemotherapy/Neoadjuvant Endocrine Therapy/Upfront Surgery for ER+/Her2- Disease
Anita Mamtani, MD
7:45–7:48 pm — Case Presentation
7:48–8:00 pm — Nodal surgery after Neoadjuvant Chemotherapy
Mediget Teshome, MD
8:00–8:03 pm — Case Presentation
8:03–8:15 pm — Atypias
Katherine Yao, MD
8:15–8:18 pm — Case Presentation
8:18–8:20 pm — Breast Abscesses/Fistulas/Squamous Metaplasia of Lactiferous Ducts (SMOLD)
Katrina Mitchell, MD
8:20–8:23 pm — Case Presentation
8:23–8:33 pm — Idiopathic Granulomatous Mastitis
Sarah Blair, MD
8:33–9:00 pm — Q&A
9:00 pm — Adjourn
Faculty:
Photo
Chair—Kari Rosenkranz, MD
Dartmouth-Hitchcock Medical Center
Lebanon, NH
Photo
Zahraa Al-Hilli, MD, MBA
Cleveland Clinic
Cleveland, OH
Photo
Sarah Blair, MD
University of California, San Diego
La Jolla, CA
Photo
Chandler Cortina, MD, MS
Medical College of Wisconsin
Milwaukee, WI
Photo
Anita Mamtani, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Photo
Katrina Mitchell, MD
Ridley Tree Cancer Center
Santa Barbara, CA
Photo
Mediget Teshome, MD
UCLA Health/DGSOM
Los Angeles, CA
Photo
Katherine Yao, MD
NorthShore University HealthSystem
Evanston, IL
References:
  1. Damin AP, Zancan M, Melo MP, Biazus JV. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach. Breast Cancer Res Treat. 2021 Apr;186(2):527-534. doi: 10.1007/s10549-020-06011-8. Epub 2020 Nov 9. PMID: 33165710.
  2. Wang T, Baskin AS, Dossett LA. Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review. JAMA Surg. 2020 Aug 1;155(8):759-770. doi: 10.1001/jamasurg.2020.0322. PMID: 32492121; PMCID: PMC10185302.
  3. Mann JM, Wu X, Christos P, Nagar H. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era. Clin Breast Cancer. 2018 Aug;18(4):e477-e493. doi: 10.1016/j.clbc.2017.09.001. Epub 2017 Sep 19. PMID: 29031423; PMCID: PMC5858981
  4. Abram Recht et al., Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. JCO 34, 4431-4442(2016) DOI:10.1200/JCO.2016.69.1188
  5. Remick J, Amin NP. Postmastectomy Breast Cancer Radiation Therapy. [Updated 2023 Jan 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: ncbi.nlm.nih.gov/books/NBK519034/
  6. Jagsi R, Abrahamse P, Morrow M, Griggs JJ, Schwartz K, Katz SJ. Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer. 2009 Mar 15;115(6):1185-93. doi: 10.1002/cncr.24164. PMID: 19180636; PMCID: PMC3905748.
Disclosures:
Use the link below to view disclosure information for all individuals and groups involved in the planning, implementation, and evaluation of this educational activity.
View Disclosure Information (pdf)